SEC Form D · Amendment · filed April 6, 2017
Novita Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Jue J. Zhang · New York, NYExec · DirectorChenjian J. Li · New York, NYDirectorDavid J. Moy · New York, NYExecXin-Yun Y. Huang · New York, NYDirectorChristy Y. Shue · New York, NYExec · DirectorElliot S. Favus · Mt. Pleasant, SCExec · DirectorJustin Mahoney · Stamford, CTExec · DirectorDaniel Sparks · Stamford, CTExecTony W. Bartsh · Mt. Pleasant, SCDirectorKevin Gasvoda · Stamford, CTDirectorStephen D. Schroeder · San Francisco, CAExec · DirectorPassco Parker Manager, LLC · Irvine, CADirectorSacks Ventures GP I, LLC · SAN FRANCISCO, CAExec · DirectorPassco Parker Depositor, LLC · Irvine, CAExecRichard O. Fortmann · San Francisco, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗